Search
for
Sort by
Research 901–930 of 1000+
- Leydig Cell Hyperplasia and Adenomas in Mice Treated with Finasteride, a 5α-Reductase Inhibitor: A Possible Mechanism
- Acne in women
- Is skin microneedling a good alternative method of various skin defects removal
- 5α-Reductase Inhibitors, Chemical and Clinical Models
- Managing polycystic ovary syndrome in primary care
- Nonsurgical Therapy for Hair Loss
- Next-Gen Therapeutics for Skin Cancer: Nutraceuticals
- Androgenetic Alopecia
- Hair loss among transgender and gender‐nonbinary patients: a cross‐sectional study
- The great atopic diseases epidemic: does chemical exposure play a role?
- A Case of Familial Male-limited Precocious Puberty with a Novel Mutation
- Intricate diagnosis due to falsely elevated testosterone levels by immunoassay
- Correlation Between Nongenomic Action of C19-Steroids and COVID-19 Severity
- The serum evaluation of sex hormones including DHEAs, DHT, testosterone in oral lichen planus patients
- Compounding as a Current Therapeutic Option in Dermatology
- Immunohistochemical Study on the Hair Growth Promoting Effect of Yonnyuniksoogobon-dan
- The Effect of Finasteride on Serum Cortisol and testosterone Levels in Rats
- Review on Diagnostic and Managerial Consequences of PCOS Among Females
- What’s new in the treatment of hair loss?
- Fibrosing Frontal Alopecia: A comprehensive study to understand its etiology
- BH03: Systemic sclerosis and frontal fibrosing alopecia: a novel combination of scarring alopecia
- Minoxidil oral en alopecia androgénica: estudio retrospectivo acerca de su seguridad en práctica clínica real
- Periungual lesions secondary to chemotherapy with docetaxel
- Hair Disorders
- Testosterone and female sexuality: A skeptical view
- USE OF SPIRONOLACTONE IN COMBINATION WITH AN ORAL CONTRACEPTIVE IN TREATMENT OF HIRSUTISM
- Hair disorders update: Alopecia to hirsutism
- Functional Ingredient Mapping in PCOS Formulations: Hormonal Excess
- Efectos del minoxidilo en formulación oral en pacientes barosensibles
- The effect of finasteride, a 5 alpha-reductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldness.